Рестеноз после коронарного стентирования у больных с метаболическим синдромом
Аннотация
Об авторах
Н. М. ДаниловРоссия
Т. Т. Горгадзе
Россия
А. П. Савченко
Россия
И. Е. Чазова
Россия
Список литературы
1. Myers P.R, Webel R, Thondapu V et al. Restenosis is associated with decreased coronary artery nitric oxide synthase. Int J Cardiol 1996; 55: 183-91.
2. Wu T.C, Chen Y.H, Chen J.W et al. Impaired forearm reactive hyperemia is related to late restenosis after coronary stenting. Am J Cardiol 2000; 85: 1071-6.
3. Ikeda U, Yamamoto K, Maeda Y et al. Endothelin-1 inhibits nitric oxide synthesis in vascular smooth muscle cells. Hypertension 1997; 29: 65-9.
4. Piatti P.M, Fragasso G, Monti L.D et al. Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimetylarginine levels. Circulation 2003; 107: 429-36.
5. Piatti P.M, Colombo A et al. Association of Insulin Resistance, Hyperleptinemia, and Impaired Nitric Oxide Release With In-Stent Restenosis in Patients Undergoing Coronary Stenting. Circulation 2003; 108: 2074-81.
6. Cooke J.P, Oka R.K. Does leptin cause vascular disease? Circulation 2002; 106: 1904-5.
7. Recchia F.A, Vogel T.R, Hintze T.H. NO metabolites accumulate in erythrocyte in proportion to carbon dioxide and bicarbonate concentration. Am J Physiol Heart Circ Physiol 2000; 279: H852-6.
8. Piatti P, Fragasso G, Monti L.D et al. Endothelial and metabolic characteristics of patients with angina and angiographically normal coronary arteries: comparison with subjects with insulin resistance syndrome and normal controls. J Am Coll Cardiol 1999; 34: 1452-60.
9. Yamagishi S.I, Edelstein D, Du X.L et al. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001; 276: 25096-100.
10. Wallace A.M, Mc Mahon A.D, Packard C.J et al. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 2001; 104: 3052-6.
11. Doehner W, Rauchhaus M, Godsland I.F et al. Insulin resistance in moderate chronic heart failure is related to hyperleptinemia, but not to norepinephrine or TNF-alpha. Int J Cardiol 2002; 83: 73-81.
12. Soderberg S, Stegmayr B, Ahlbeck-Glaber C et al. High leptin levels are associated with stroke. Cerebrovasc Dis 2003; 15: 63-9.
13. Versaci F, Gaspardone A, Tomai F et al. Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS Study). J Am Coll Cardiol 2002; 40: 1935-42.
14. Schillinger M, Exner M, Mlekusch W et al. Acute - phase response after stent implantation in the carotid artery: association with 6-month in - stent restenosis. Radiology 2003; 227: 516-21.
15. Matthews D.R, Hosker J.P, Rudenski A.S et al. Homeostasis model assessment: insulin resistance and beta - cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
16. Bergman R.N. Lilly lecture 1989. Toward physiological understanding of glucose tolerance: minimal - model approach. Diabetes 1989; 38: 1512-27.
17. Takagi T, Yoshida K, Akasaka T et al. Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in non diabetic patients: a serial intravascular ultrasound study. J Am Coll Cardiol 2000; 36: 731-8.
18. Iozzo P, Chareonthaitawee P, Dutka D et al. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes 2002; 51: 3020-4.
19. Kahn S.E. The relative contributions of insulin resistance and beta - cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003; 46: 3-19.
20. Bergman R.N, Finegood D.T, Kanh S.E. The evolution of beta - cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest 2002; 32 (suppl. 3): 35-45.
21. The Decode Study Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 1999; 354: 617-21.
22. Norhammar A, Tenerz A, Nilsson G et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359: 2140-4.
23. Morice M.C, Serruys P.W, Sousa J.E et al. A randomized comparison of a sirolimus - eluting stent with a standard stent for coronary revascularisation. N Engl J Med 2002; 346: 1773-80.
24. Kaiser C, Brunner-La Rocca H, Buser P et al. Incremental cost - effectiveness of drug - eluting stents compared with a third - generation bare - metal stent in a real - world setting: randomised Basel Stent Kosten EffektivitКts Trail (BASKET). Lancet 2005; 366: 921-9.
Рецензия
Для цитирования:
Данилов Н.М., Горгадзе Т.Т., Савченко А.П., Чазова И.Е. Рестеноз после коронарного стентирования у больных с метаболическим синдромом. Системные гипертензии. 2006;(1):47-50.
Послать статью по эл. почте 